Correlation Between Viking Therapeutics and Biomea Fusion
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Biomea Fusion, you can compare the effects of market volatilities on Viking Therapeutics and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Biomea Fusion.
Diversification Opportunities for Viking Therapeutics and Biomea Fusion
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Biomea is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Biomea Fusion go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Biomea Fusion
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.77 times more return on investment than Biomea Fusion. However, Viking Therapeutics is 1.3 times less risky than Biomea Fusion. It trades about -0.31 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.25 per unit of risk. If you would invest 6,297 in Viking Therapeutics on September 12, 2024 and sell it today you would lose (1,376) from holding Viking Therapeutics or give up 21.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Biomea Fusion
Performance |
| Timeline |
| Viking Therapeutics |
| Biomea Fusion |
Viking Therapeutics and Biomea Fusion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Biomea Fusion
The main advantage of trading using opposite Viking Therapeutics and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |